Greg J. Divis

Greg J. Divis is CEO at AVADEL PHARMACEUTICALS PLC (AVDL). They have made 3 open-market trades across 1 company since 2017, most recently 2019-11-15.

Get an email the next time Greg J. Divis files.Follow for free

3 open-market purchases totalling $292K since 2017, never a sale. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
AVDL	86,100	$1.9M
KVA	1,225	—
Total		$1.9M

Shares reported on the most recent Form 4, priced at the 2019-11-19 close. 1 holding could not be priced and is excluded from the total.

Grade by Ticker

CAVDL

2 trades

Get an email the next time Greg J. Divis files

Free account. One email when the next filing comes in.

Follow Greg J. Divis for free

Buy Track Record

Filings3

Only 3 discretionary filings — too few to score

Discretionary filings only. 10b5-1 plan trades, tax withholding and option exercises are excluded, and each column is one row per filing rather than per execution lot.

Volume by Type

POpen-Market Purchase

$292K

3 filings

MOption Exercise

$35K

1 filings

AAward/Grant

2 filings

1 filings

Companies

Trade History

3 total

AVDLBUY

$97K

2019-11-157d: +20.2%

Large Holdings IncreaseOpportunistic BuyTop TradeMomentum Buy

•Increased holdings by 28%
•2nd largest purchase, out of 3
+2 more

AVDLBUY

$96K

2018-06-267d: +1.9%

Large Holdings IncreaseOpportunistic BuyTop TradeDeep Dip Buy

•Increased holdings by 48%
•3rd largest purchase, out of 3
+2 more

AVDLBUY

$99K

2017-09-127d: -0.7%

First-Time BuyerOpportunistic BuyTop Trade

•Largest purchase ever, out of 3
•Stock down -14% in previous 3 months

Ticker	Type	Traded	Filed	Price	Value	7d Stock	30d Stock	90d Stock
AVDL	BUY	2019-11-15	2019-11-19	$5.13	$97K	+20.2%	+23.1%	+36.0%
AVDL	BUY	2018-06-26	2018-06-27	$6.00	$96K	+1.9%	-2.9%	-32.9%
AVDL	BUY	2017-09-12	2017-09-14	$9.32	$99K	-0.7%	+5.4%	-10.0%

Related Insiders

Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.